Myocardiotoxicity of 5 Fluorouracil
โ Scribed by B. Coronel; O. Madonna; A. Mercatello; A. Caillette; J. F. Moskovtchenko
- Publisher
- Springer
- Year
- 1988
- Tongue
- English
- Weight
- 123 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1432-1238
No coin nor oath required. For personal study only.
โฆ Synopsis
We report a case of specific myocardiotoxicity due to 5 F.U. not previously described in man. A 41-year-old man was admitted to the ICU for heart and renal failure, appearing 24 h after 5 days treatment with 5 F.U. and cis-platinum. Dopamine was necessary to maintain blood pressure. Two-D echocardiography and a right heart catheterisation confirmed the alteration of myocardial contractility. After 2 weeks a complete cardiac recovery occurred.
๐ SIMILAR VOLUMES
Twelve patients with neoplasia undergoing therapy with 5-Buorouracil (5-FU) were immunized with Escherichiu coli Vi antigen a n d tetanus toxoid to test the primary and secondary humoral immune responses. Skin sensitization was attempted with 2,4-dinitrochlorobenzene, and a battery of common microbi
Thirty-eight patients with metastatic colorecal carcinoma were treated with 5-fluorouracil (5-FU), and 38 patients were treated with the combination of 5-FU, cyclophosphamide, and methotrexate. In terms of percent response, response duration, and survival there was no apparent difference between the
## Abstract It has been reported that plasma albumin concentrations were significantly lower in cancer patients than those in the healthy volunteers, and the expression and mRNA level of hepatic microsomal cytochrome P450 (CYP) 1A2 increased in mutant Nagase analbuminemic rats (NARs). After intrave